Jay Mehta, MD, MSEd: Understanding Pediatric Rheumatologic Lab Results


Dr. Mehta highlights some of the challenges that come with treating pediatric rheumatology patients and how he handles them.

Interpreting rheumatologic laboratory results can be challenging, not only for pediatricians, but for parents too, Jay Mehta, MD, MSEd, Associate Professor of Clinical Pediatrics, Children's Hospital of Philadelphia, explained.

In his presentation, Red Flag or Red Herring: Rheumatologic Lab Evaluation of Musculoskeletal Pain for the American Academy of Pediatrics conference, Mehta discussed examples of patient presentations that pediatricians often see and how to properly screen them.

There are specific challenges that accompany treating pediatric patients. Mehta used the example of how arthritis doesn't present with pain in 25% of children. It can appear much more subtly as a limp or morning stiffness.

Being able to differentiate between something truly alarming when screening lab results, as opposed to something that's only seemingly alarming is important but difficult if you're not sure what to look for. And that's what Mehta aimed to address in his conference presentation.

"As rheumatologists what we do is we take the history, we take the exam, we take the labs, and put it all together," Mehta said. "One of the things that I love about pediatric rheumatology is, it does feel like putting the puzzle pieces together, but sometimes those puzzle pieces could be missing, or they may look a little bit differently."

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.